4Clinics   Report issue

For profit Phase 1 Phase 2
Founded: Sao Paulo Brazil (2015)

Organization Overview

First Clinical Trial
2018
NCT03321981
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

4Clinics

Active Ingredients

Drugs in Phase 2 Trials (3)

mcla-128 (1 trial)

trastuzumab (herceptin) (1 trial)

vinorelbine (navelbine) (1 trial)

Drugs in Phase 1 Trials (1)

mcla-158 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Colorectal Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4